leuprolide

(redirected from Lupron depot-ped)
Also found in: Dictionary.

leuprolide

 [loo-pro´līd]
a synthetic analogue of gonadotropin-releasing hormone, used in the form of the acetate ester as an antineoplastic agent, treatment for endometriosis, and gonadotropin inhibitor. Administered subcutaneously or intramuscularly.

leuprolide

/leu·pro·lide/ (loo-pro´līd) a synthetic analogue of gonadotropin-releasing hormone, used in the form of the acetate ester as an antiendometriotic agent, antineoplastic, and gonadotropin inhibitor.

leuprolide

(lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.

leuprolide

Viadur® An analogue of gonadotropin-releasing hormone, which has been used to manage PMS, and block ovarian or testicular hormone production in Pts with hormonally active CA. See PMS.
References in periodicals archive ?
For additional information on Lupron Depot-PED for the treatment of central precocious puberty, visit www.
Use for Lupron Depot-PED (leuprolide acetate for depot suspension)
Children should not receive any formulation of Lupron Depot-PED if they have experienced any type of allergic reaction to Lupron Depot-PED or similar drugs.
Females who are or may become pregnant should not receive any formulation of Lupron Depot-PED.
During the first weeks of Lupron Depot-PED treatment, signs of puberty, such as vaginal bleeding, may occur.
The initial response to Lupron Depot-PED should be monitored, as well as the continued response during treatment, as clinically needed.
The most common side effects for any GnRH agonist, including Lupron Depot-PED, are injection site reactions/pain including abscess, general pain, headache, fluctuating emotions, and hot flushes/sweating.
The most frequent adverse reactions in Lupron Depot-PED studies were pain; acne; injection site reactions, including pain, swelling and abscess; rash, including a painful rash with fever, blisters/sores, and facial swelling; vaginitis/vaginal bleeding/vaginal discharge; increased weight; and altered mood.
The availability of Lupron Depot-PED is an important step forward in the treatment of this disorder.
We feel that Lupron Depot-PED will improve the quality of life for many of the children with this disorder.